January 6, 2026

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

Today’s edition starts in Washington, where a cannabis price war is colliding with the five-store cap and new control limits, putting proof and enforcement capacity at the center of the market’s next chapter. We also track the federal rescheduling push as a process story, with the DEA appeal still sitting upstream of any final rule that can survive court scrutiny. Florida and Michigan round out the day with courts and tax posture driving real planning decisions, from ballot access fights to wholesale tax litigation.

Today’s edition is supported by THC Group, which is proud to offer this brief for free to subscribers, and The Hybrid podcast hosted by former regulators Shawn Collins and Erik Gundersen. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.

🌲 Washington consolidation and caps
ā³ Schedule III appeal and record risk
šŸ’° State tax and ballot fights

It is one thing to know. It is another to prove it.

Start here — the day’s most important development, decoded for impact.

šŸ“Œ What Happened: Cannabis Observer kicked off a reported series on Washington’s price war and the contract structures that let coordinated retail groups act bigger than the five-store cap suggests. The reporting, led by Cara Wietstock with editing and distribution credited to Gregory Foster, describes 50% off as the default shelf price in many places and explains how that pressure rolls downhill into wholesale terms. The series also tracks the Legislature’s response in SB 5403, which is now law and took effect January 1st. The law aims to limit coordinated control and shared branding beyond five retail businesses, and it arrives before the state has put out crisp, practical guidance on what it will treat as coordinated control. Some companies are already rebranding and reshuffling in response, changing what customers see while trying to keep their back-end systems steady.

šŸ’” Why It Matters: Washington has a simple problem with a hard fix. When half-off is the normal shelf tag, somebody upstream is eating it, and it usually is the people with the least leverage. Growers and processors cannot take their product to ten other channels. They sell into the licensed system or they do not sell at all. If a small group of retail platforms can act like a chain through contracts and shared decision-making, they can set terms the rest of the market has to live with. SB 5403 puts that reality on the state’s desk and asks a basic question: who is really in charge of these stores. The answer is rarely on the storefront. It is in the contracts, the shared services, and how and where the decisions ultimately get made.

ā

🧠 THC Group Take: This is the kind of structure regulators spend an inordinate amount of time chasing. It can feel like looking under cups in a shell game, trying to find where the ball is. I lived it in Massachusetts and I have seen it again and again in other states, where everyone thinks they know who is calling the shots but nobody can prove it cleanly. That experience is where I picked up a simple philosophy: it is one thing to know something, and it is another thing altogether to prove it. Proof is what survives an appeal. Proof is what holds up in court.

Washington’s new law will rise or fall on that distinction. If Washington writes enforcement as a perception test, it will lose. If Washington builds enforcement like an evidentiary record, it has a shot. That means defining coordinated control in a way staff (and the industry) can apply consistently, then training investigators to collect the kind of facts that stand up later. Shared payroll, shared purchasing authority, shared pricing direction, shared inventory systems, shared vendor negotiations, shared decision-making meetings. Those are the places control shows up, and those are the places the record has to live. Control is squishy.

For the market, this is not just a compliance memo. Retail groups that have relied on management and brand structures should mind the law’s newfound scrutiny. Merely papering a separation that does not actually exist will fail the first serious inquiry. Producers should assume the buying side will stay concentrated through a transition and protect themselves accordingly, especially on credit and promotional spend. For regulators, the quickest win is clarity. Put out guidance that tells the market what evidence matters, how the state will test independence, and what behavior will trigger deeper review. Washington can still land this plane, yet it needs to build for the courtroom, not for the press release.

Fast-moving headlines, flagged for what matters.

DEA told the administrative court the rescheduling appeal remains pending at the Administrator level, with no new briefing schedule. The appeal focuses on bias claims and improper communications, so it sits upstream of any merits hearing and upstream of a final rule that can survive review. The White House can press for speed, yet the agency still has to clear the appeals logjam and restore a viable hearing lane. That gap keeps counsel and investors working in ranges rather than dates. Opponents will keep hunting for procedural error because it moves faster than a science fight. (Marijuana Moment)

An industry-funded political committee reported another $1.05 million in contributions to Trump’s aligned super PAC, including a $1 million July transfer and a $50,000 November contribution. The new filings bring total giving to $2.05 million during 2025 and land in the same season as executive direction to finish Schedule III. The optics sharpen a transactional narrative that critics can use in oversight and litigation messaging. DOJ and DEA now carry added incentive to keep every step documented and defensible. The political spend may not change the outcome, yet it will shape the fight around the outcome. (Marijuana Moment)

Sen. Rick Scott repeated the gateway drug claim as DOJ moves toward a Schedule III finish. Florida voters delivered about 56% support for adult use in 2024 and still lost on the 60% threshold, which signals durable public support even when amendments fail. Scott’s framing fits a moral argument that plays well in hearings and letters. It also gives rescheduling opponents language that travels cleanly into court filings and oversight demands. The administration will answer with record discipline because the politics are already hardened. (Marijuana Moment)

DEA finalized 2026 production quotas and raised ceilings for psychedelics used in research, including psilocybin, psilocyn, and DMT. The near-term effect is more compliant supply for registered manufacturers and fewer bottlenecks for studies already underway. For cannabis readers, the point sits in the plumbing: federal research still runs through quotas, registrations, and tight control of lawful supply. That same machinery will shape what Schedule III access means in practice. Labs follow paperwork, even when markets chase headlines. (Marijuana Moment)

The U.S. Tax Court sent a medical cannabis collection case back to IRS Appeals after finding the appeals officer abused discretion and missed key points. The dispute involves a 2021 280E-driven liability and an offer in compromise that the court found was handled poorly. This matters because collection fights often turn on documentation quality and process fairness. Other taxpayers will cite this when Appeals shortcuts analysis or ignores the record. IRS loses momentum when its own file looks careless. (Bloomberg Tax)

ESOPs are back in cannabis finance conversations because the tax math can look attractive under 280E in S corporation structures with an ESOP shareholder. The pitch sells employee ownership, liquidity, and potential tax relief in one package. The structure also brings fiduciary duties, annual valuations, and compliance demands that punish weak governance and sloppy books. Shops with predictable cash flow can explore it seriously, while thin-margin operators will feel repurchase obligations fast. The board conversation should start with durability, not with tax dreams. (Cannabis Business Times)

Florida’s attorney general asked the state Supreme Court to block a 2026 adult-use amendment before voters can weigh in. The argument targets the ballot summary and leans on federal illegality framing, a procedural choke point that avoids a persuasion campaign. Business groups joined the push, signaling coordinated strategy through the courts. Florida just saw roughly 56% support fall short in 2024 due to the 60 percent threshold, so the politics remain live. If the court bites, capital planning stays cautious and campaign dollars shift back to lawyering and drafting. (Marijuana Moment)

Florida lawmakers filed bills that would ban open containers of medical marijuana, hemp, and THC products in vehicles, including beverages, for drivers and passengers. The proposals also aim to revive vehicle searches tied to smell, pushing back against recent court skepticism in a state with legal medical cannabis and lawful hemp. Penalties escalate across repeat conduct and the structure presumes the driver owns open product unless it is secured or clearly controlled by a passenger. Patients and compliant buyers will adjust behavior quickly, with trunks and locked cases becoming standard. Roadside encounters will carry more friction because discretion will do more of the work. (Florida Phoenix)

Michigan’s new 24 percent wholesale cannabis tax is already hitting the market through higher prices and thinner margins. A Court of Claims judge declined to block the tax, and the industry challenge is continuing on a longer court timeline. Retailers will keep adjusting pricing and inventory while finance teams tighten terms, since upstream taxes make every unpaid invoice more dangerous. The legal theory turns on voter intent and process protections around ballot-passed law. Operators will plan as if the tax stays through 2026 because any relief arrives late. (Crain’s Detroit Business)

New Jersey lawmakers are moving a broad CRC reform package that pairs tougher enforcement with structural changes to commission governance. The bill directs State Police, alongside local agencies and the CRC, to build an enforcement program targeting unlicensed cannabis businesses with closure authority and prosecution referrals. It also opens the door to changes inside the legal market, including clearer rules on multi-location operations and new guardrails on representation tied to state government connections. Supporters frame it as consumer protection and market legitimacy, while critics warn it risks politicizing commission work. If it passes, expect more coordinated enforcement and more scrutiny of CRC independence at the same time. (Heady NJ)

A referendum campaign is collecting signatures to put Ohio’s new restrictions to a vote and suspend implementation while the process runs. The law rewrites parts of the voter-approved adult-use framework and pushes intoxicating hemp products toward the dispensary channel after the governor vetoed a transition runway. Organizers argue the new rules recriminalize behavior voters understood as legal, including possession conditions that create routine exposure. The next hurdle is certification followed by roughly 248,000 valid signatures to qualify statewide. If they clear it, Ohio enters a planning freeze that hits regulators, retailers, and product makers together. (Columbus Underground)

Oklahoma’s Bureau of Narcotics is using new public numbers to argue the state remains a major source for illegal marijuana trafficking tied to licensed and unlicensed grows. The agency points to large plant seizures, major processed weight seizures, and hundreds of arrests tied to ongoing investigations. Investigators keep pointing to straw ownership and paperwork fraud as the common entry point. The state also highlights a sharp decline in registered grows, signaling continued tightening that will raise documentation and inspection pressure on compliant operators. The market keeps paying for a program built for speed before it was built for verification. (KTUL)

Colorado says MC Global Holdings, tied to the Vivimu brand, violated a settlement that required a clear stop to Colorado sales and cleaner marketing practices. Investigators say the company kept advertising and selling into the state while describing the restriction in a way consumers could read as limited. The state also raised concerns about testing tied to an out-of-state lab Colorado does not certify for this work. A new penalty follows with consequences designed to escalate quickly if violations continue. The compliance lesson is basic: settlement terms have to live in operations, not in disclaimers. (Denver Post)

A customer peeled back adult-use stickers on flower and found intact medical labels underneath, including a different strain name and a Curaleaf facility address. Maine allows layered labels and treats the visible sticker as the compliance record at retail, so mismatches can slide through without an automatic flag. Maine’s medical side lacks mandatory testing and track and trace, which raises sourcing and quality-control questions when packaging overlaps. This is the kind of plausible error that turns into a recall and reputational issue fast. A compliance system that relies on what a human can see will miss what a human does not think to check. (Portland Press Herald)

University of Washington researchers are in grow and processing facilities measuring airborne hazards and tracking respiratory symptoms tied to handling and packaging. The work follows fatalities linked to work-related asthma, a hard reminder that legal markets still carry occupational risk. Researchers are building task-level exposure data to identify what drives breathing-zone exposure in high-throughput rooms. Owners already point to dust, ventilation gaps, and inconsistent protective practices as likely culprits. Insurers and workplace regulators will use real data to define what reasonable controls look like. (Cascadia Daily News)

Wyld announced an acquisition of Grƶn, combining two established edibles platforms with durable shelf presence across multiple regulated markets. The deal points to scale as strategy in a category where manufacturing consistency and distribution leverage matter as much as branding. Retailers get a deeper portfolio with fewer supply surprises, which tightens shelf competition for mid-tier brands. Smaller regional edibles companies will feel more pressure in pricing, promos, and placement. Exit value will track repeatability and back-office discipline. (Cannabis Business Times)

Nebraska’s Medical Cannabis Commission approved another round of emergency regulations and voted to approve a cultivator license as it builds the supply side of a voter-authorized program. The rules take effect once the governor signs them, and the commission plans another hearing as it continues refining the process. Advocates pressed for speed, describing patients who already rely on cannabis to function. The commission also voted to create a standalone website, a small signal that basic infrastructure is still catching up to the mandate. The program keeps moving on paper while the market start remains uncertain. (KETV)

The deeper pattern behind today’s moves — and why it matters next.

Rescheduling Will Turn on the Record

🧾 Context: The document that matters most looks like paperwork because it is paperwork.

DOJ published a proposed rule on May 21, 2024 to move marijuana from Schedule I to Schedule III. That put the whole thing on the only track that counts in Washington: a docket, public comments, an administrative record, and a final rule that has to survive review by people who do not care what you meant.

President Trump’s December 18 executive order did what executive orders usually do. It grabbed an existing process by the collar, told DOJ to move, and pointed back to that 2024 proposal as the vehicle.

You can feel the industry leaning forward. You can also see the opposition getting practical. Hiring Bill Barr is not messaging. It’s a litigation decision. It signals they plan to fight this in court, on process, not in public, on persuasion.

I have been chirped online for saying DEA should finish the job, with the predictable reminder that the Attorney General can pull the lever herself. Sure. The point is not which signature or stamp goes on the filing. The point is what happens next. A final rule brings a lawsuit, and the lawsuit will live in the mechanics: authority, delegation, notice, record, and the little seams that can turn into a big pause.

šŸ”Ž What It Signals: Rescheduling has two lives. One life is public. It’s the part where people argue about compassion, science, public safety, kids, freedom, and whether the country should keep pretending.

The second life is quieter, and it tends to decide the actual effective dates. It lives in administrative law. A judge reviews and evaluates what the government did, how it explained itself, and whether it followed the steps the statute requires. Judges live on verbs. Considered. Responded. Explained. Supported.

Here’s the uncomfortable part, and it is the part I keep coming back to. This can turn on something that looks clerical when you say it out loud. Not because the issue is small, but because the law treats ā€œhow you did itā€ as inseparable from ā€œwhether you were allowed to do it.ā€

Prohibitionists know they don’t need to win a cultural debate. Courtroom strategy rewards a narrower win. Bill Barr was hardly known for his press conferences and Sunday show hits. He’s a litigator. He’ll find a procedural hook and ask for a stay or an injunction. He’ll ask the court to send it back to the agency for more hearings. More process. Those delays will keep everyone, including markets, cautious. Congress has no vote in a courtroom. There is no ballot. It is the old-timey Washington litigator vs. the United States in front of a judge who is not persuaded by polls. SAM and their gang of prohibitionists wants that forum, because they know they lose everywhere else.

So the risk, therefore, sits in the execution. An explanation that skips a step. A response to significant comments that reads thin. A record that leans too hard on a few off-topic citations. A final rule that drifts from what was proposed without a sturdy explanation for why. These are the little seams that get pulled until they become a pause.

Anyone who has worked inside government knows that last stretch. The phone never stops. Everyone starts asking what is taking so long. They’re planning their press release. The pressure to move fast starts whispering that the details can be cleaned up later. ā€œLaterā€ is where lawsuits live. A rushed sentence in the preamble becomes a quote in a brief. A missed step becomes the reason a judge hits pause.

ā

🧠 THC Group Take: I keep coming back to a pretty unromantic view of this.

Assume litigation the day a final rule posts. Treat that as ordinary, then plan like you mean it.

I see three potential tracks, two of which are more likely than the first.

Track one: the rule goes final and get implemented.
Track two: the rule goes final and implementation slips under legal pressure.
Track three: the rule goes final and a court freezes the effective date while the case moves.

Run each of those tracks through real decisions impacting your business: banking, insurance, diligence, vendor terms.

That’s the moment the private sector tells you what it believes. Banks will get cautious. Insurers will start asking more questions. Boards start remembering and using words like ā€œfiduciaryā€ and ā€œprudenceā€ and meaning it. The counterparty who used to smile and sign now all of a sudden wants receipts.

So keep your own house in order in the ways that matter when scrutiny rises. Claims that you can defend. Labels that read clean. Documentation that a skeptical outsider can follow without a guided tour. An adverse event plan that works on a Tuesday afternoon, with real names and real phone numbers.

Rescheduling may still land. Believe it or not, I’m cautiously optimistic about it. The market, though, treats it as settled when courts stop offering easy reasons to hit pause. Until then, discipline wins. It keeps you moving while everyone else waits for certainty that never arrives.

From the hearing room to the comment section — we’re watching it all.

šŸ™ Australia got a blunt message from California’s Sisters of the Valley: partial decriminalization keeps cannabis in black and brown bags, and that leaves consumers with untested product and policymakers with no accountability lever. Their warning lands as Australia’s medical market expands while adult use stays largely illegal, a setup where demand moves faster than governance. (news.com.au)

šŸ¤– Beverage Information Group dropped a new podcast on how AI is reshaping alcohol, from pricing and assortment to compliance workflows. The guest also connects the dots to hemp-derived THC drinks and the legal fault lines that will decide who gets stable shelf space. (Beverage Information Group)

🧬 Researchers resurrected extinct cannabis enzymes and found early synthases behaved like generalists before evolution split them into specialized cannabinoid machinery. The industrial implication is real, since hardier enzymes could make fermentation-based cannabinoids easier to produce consistently. (Wageningen University and Research)

🄊 Mike Tyson and Ric Flair sued former partners tied to a cannabis licensing platform, alleging fraud and self-dealing. Celebrity cannabis lives and dies on controls, and this kind of fight tightens contracts across the category fast. (Chicago Business)

Recommended for you